man hiking

Developing Innovative Therapies that Treat or Reverse Disease

Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and promote the regeneration of damaged tissue.

Learn more about our approach
Woman hiking
Heart rendering describing how CD34+ regenerative therapy works
Caladrius Biosciences lightbulb icon



Learn more about our CD34+ technology

ESCaPE-CMD Patient Testimonial Video

Caladrius Biosciences cell rendering
Caladrius Biosciences scientific data icon

Mission-Driven Science

Our proprietary CD34+ cell therapy platform has generated a multi-product development pipeline with the potential to provide curative therapies to people in need. 

Patient examination for regenerative medicine
Researcher using a computer for cell therapy development
EKG reading while testing for CMD in cell therapy development
Electrocardiogram for cell therapy development in ischemic tissue repair
Caladrius Biosciences publication icon



Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

CD34+ Cell Therapy Significantly Reduces Adverse Cardiac Events, Health Care Expenditures, and Mortality in Patients with Refractory Angina

Testing for Coronary Microvascular Dysfunction

Autologous CD34+ Cell Therapy for Ischemic Tissue Repair


Join Our Team

Our mission is to discover, develop and deliver innovative therapeutics in areas of unmet medical need that improve patient lives. We can accomplish that goal through the collective efforts of talented individuals who work together to advance scientific research. We place a premium on integrity, respect, diversity and collaboration. These values have helped us to build a growing company that offers professionally rewarding careers with the opportunity to make a meaningful contribution to patients in need. 

Audience Applauding Speaker After Conference Presentation